With E. Rand Sutherland, MD, MPH, FCCP; hosted by Leo C. Rotello, MD, FCCP, FCCM, FACP

In this clinical discussion, E. Rand Sutherland, MD, MPH, FCCP, will update you on recent COPD research and treatment guidelines and help you consider how this information may be applied to clinical practice to obtain better outcomes for patients with COPD. (View PDF)

Overview

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of morbidity and mortality in the United States. However, prevalence in morbidity data greatly underestimate the total COPD burden because the disease is frequently not diagnosed until it is clinically apparent and moderately advanced. New understanding of the pathophysiology of COPD has led to interventions that may have the potential to modify or control disease progression and prevent or delay its effects.

• Differentiate COPD from asthma in adult patients

• Describe the changes in COPD management that have made it a more treatable disease

• Articulate the advantages of early COPD diagnosis and treatment

Learner Participation to Earn Credit

• Review the course material

• Complete the online post-test with a score of 70% or higher

• Complete online program evaluation

• Participation in the self-study activity should be completed in approximately 60 minutes

As a provider of CME and CE activities that are accredited by AANP, AAPA and AARC, MEBN must ensure balance, independence, objectivity and scientific rigor in all of its CME activities. All faculty participating in these activities are expected to disclose any or no relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of any or no relationship(s) will be listed prior to any educational activity. All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the CME activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Disclaimer
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.

Certificate Fees

CE-TODAY offers FREE continuing education (CE) credits to recipients of the CD-ROM or the CE-TODAY journal. Enter the CE Code listed on the CD-ROM or in the journal when prompted. This free offer expires on May 26, 2007. All others will be assessed a $10.00 processing fee.